ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,308.13
0.09%
Dow Jones
39,806.77
-0.49%
US Dollar vs MXN
16.56625
0.07%
Brent Oil
83.215
-0.38%
Bitcoin
71,009.91
-0.62%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE
  6. Amryt Pharma Plc (AMYT)

  7. Amryt Pharma Plc (AMYT) Noticias

AMYT

Amryt Pharma (AMYT)

Amryt Pharma Plc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:AMYT
FechaHoraFuenteTítuloSímboloCompañía
11/01/202208:39Alliance NewsAlliance NewsIN BRIEF: Amryt Pharma delists from AIM as trading shifts to New YorkLSE:AMYTAmryt Pharma Plc
06/01/202211:29UK RegulatoryFTSE Russell Amryt PharmaLSE:AMYTAmryt Pharma Plc
06/01/202201:00UK RegulatoryAmryt Pharma plc Key Dates For Aim DelistingLSE:AMYTAmryt Pharma Plc
04/01/202206:00UK RegulatoryAmryt Pharma plc The Lancet Diabetes & Endocrinology Publishes Positive Results For The Mpowered Phase 3 Trial For Mycapssa(R) (oral octreotide) In Acromegaly PatientsLSE:AMYTAmryt Pharma Plc
04/01/202201:00UK RegulatoryAmryt Pharma plc Total Voting RightsLSE:AMYTAmryt Pharma Plc
30/11/202101:00UK RegulatoryAmryt Pharma plc Director/Pdmr ShareholdingLSE:AMYTAmryt Pharma Plc
23/11/202107:21Dow Jones NewsAmryt Pharma Says FDA Extends Oleogel-S10 New Drug Application Review by Three MonthsLSE:AMYTAmryt Pharma Plc
23/11/202106:00UK RegulatoryAmryt Pharma plc Amryt Provides Update On Regulatory Review Process For Oleogel-S10LSE:AMYTAmryt Pharma Plc
22/11/202101:00UK RegulatoryAmryt Pharma plc Amryt Announces The Cancellation Of Admission Of Its Ordinary Shares To Trading On AimLSE:AMYTAmryt Pharma Plc
09/11/202116:01Alliance NewsAlliance NewsTRADING UPDATES: Shepherd Neame losses cut; Beximco to sell Covid pillLSE:AMYTAmryt Pharma Plc
03/11/202106:00UK RegulatoryAmryt Pharma plc Amryt Reports Strong Q3 2021 ResultsLSE:AMYTAmryt Pharma Plc
01/11/202102:00RNS Non-RegulatoryAmryt Pharma PLC Amryt Supports Acromegaly Awareness DayLSE:AMYTAmryt Pharma Plc
22/10/202101:00RNS Non-RegulatoryAmryt Pharma PLC Amryt Supports Global EB Awareness Week 2021LSE:AMYTAmryt Pharma Plc
20/10/202106:00UK RegulatoryAmryt Pharma plc Amryt To Report Q3 2021 Results And Host Conference Call & Webcast On November 3LSE:AMYTAmryt Pharma Plc
19/10/202106:00UK RegulatoryAmryt Pharma plc Amryt Announces New Patents For Oleogel-S10 And Mycapssa(R)LSE:AMYTAmryt Pharma Plc
23/09/202105:59RNS Non-RegulatoryAmryt Pharma PLC Amryt Supports Global FH Awareness DayLSE:AMYTAmryt Pharma Plc
14/09/202101:32Alliance NewsAlliance NewsIN BRIEF: Amryt Pharma ups guidance again after Chiasma acquisitionLSE:AMYTAmryt Pharma Plc
13/09/202106:00UK RegulatoryAmryt Pharma plc Amryt Raises Full Year 2021 Revenue Guidance To $220m - $225mLSE:AMYTAmryt Pharma Plc
19/08/202101:00UK RegulatoryAmryt Pharma plc Amryt Issues Ordinary Shares And Total Voting RightsLSE:AMYTAmryt Pharma Plc
13/08/202107:23UK RegulatoryAmryt Pharma PLC Holding(s) in Company - ReplacementLSE:AMYTAmryt Pharma Plc
11/08/202105:30UK RegulatoryAmryt Pharma PLC Holdings in CompanyLSE:AMYTAmryt Pharma Plc
11/08/202104:36UK RegulatoryAmryt Pharma PLC Holding(s) in CompanyLSE:AMYTAmryt Pharma Plc
09/08/202106:00UK RegulatoryAmryt Pharma plc Amryt Virtual Capital Markets Event - September 13, 2021 -- 1000-1200 EdtLSE:AMYTAmryt Pharma Plc
06/08/202108:41Alliance NewsAlliance NewsIN BRIEF: Amryt hikes guidance on record second quarter resultsLSE:AMYTAmryt Pharma Plc
06/08/202106:00UK RegulatoryAmryt Pharma plc Amryt Reports Record Q2 2021 Results And Raises Fy 2021 GuidanceLSE:AMYTAmryt Pharma Plc
05/08/202109:50UK RegulatoryAmryt Pharma plc Amryt Successfully Completes Acquisition Of Chiasma, Inc., Board Appointments, Issues Ordinary Shares And Total Voting RightsLSE:AMYTAmryt Pharma Plc
28/07/202109:00UK RegulatoryAmryt Pharma plc Result Of General MeetingsLSE:AMYTAmryt Pharma Plc
12/07/202106:00UK RegulatoryAmryt Pharma plc Amryt To Report Q2 2021 Results And Host Conference Call & Webcast On August 6LSE:AMYTAmryt Pharma Plc
28/06/202106:00UK RegulatoryAmryt Pharma plc Publication Of Circular To Amryt Shareholders In Relation To The Acquisition Of Chiasma, Inc., And Posting O...LSE:AMYTAmryt Pharma Plc
15/06/202105:45UK RegulatoryAmryt Pharma plc Amryt Pharma Announces Filing Of Preliminary Registration Statement On Form F-4 In Connection With Its Propo...LSE:AMYTAmryt Pharma Plc
 Showing the most relevant articles for your search:LSE:AMYT

Su Consulta Reciente

NYSE
CVX
Chevron
AMEX
XLV
Health Care Select Sector
NYSE
KO
Coca Cola
NYSE
BAC
Bank of America
FX
EURUSD
Euro vs US Dollar
CCOM
OILBRENT
Brent Oil
CCOM
US30
US 30
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
VZ
Verizon Communications
CCOM
SILVER
SILVER
USOTC
BNPQY
BNP Paribas (QX)
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
NKE
Nike
FX
USDMXN
US Dollar vs MXN
CCOM
US500
US 500
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados